NASDAQ:VANI Vivani Medical (VANI) Stock Forecast, Price & News $0.94 +0.05 (+5.62%) (As of 09/21/2023 ET) Add Compare Share Share Today's Range$0.89▼$0.9650-Day Range$0.88▼$1.3052-Week Range$0.75▼$2.64Volume28,798 shsAverage Volume54,111 shsMarket Capitalization$47.75 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Vivani Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside644.7% Upside$7.00 Price TargetShort InterestHealthy0.75% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.00Based on 3 Articles This WeekInsider TradingAcquiring Shares$164,705 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.41 out of 5 starsMedical Sector236th out of 961 stocksElectromedical Equipment Industry6th out of 22 stocks 3.5 Analyst's Opinion Consensus RatingVivani Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, Vivani Medical has a forecasted upside of 644.7% from its current price of $0.94.Amount of Analyst CoverageVivani Medical has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.75% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Vivani Medical has recently decreased by 6.66%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldVivani Medical does not currently pay a dividend.Dividend GrowthVivani Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for VANI. Previous Next 3.9 News and Social Media Coverage News SentimentVivani Medical has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Vivani Medical this week, compared to 0 articles on an average week.Search Interest2 people have searched for VANI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Vivani Medical to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $164,705.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders55.62% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.44% of the stock of Vivani Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Vivani Medical is -2.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vivani Medical is -2.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVivani Medical has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Vivani Medical (NASDAQ:VANI) StockVivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.Read More VANI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VANI Stock News HeadlinesSeptember 19, 2023 | benzinga.comVivani Medical Director Trades $97K In Company StockSeptember 13, 2023 | finance.yahoo.comDirector Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI)September 21, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 13, 2023 | americanbankingnews.comAnalyzing Vivani Medical (VANI) and Its PeersSeptember 12, 2023 | americanbankingnews.comFinancial Review: Vivani Medical (VANI) vs. Its RivalsSeptember 12, 2023 | americanbankingnews.comHead-To-Head Survey: Vivani Medical (VANI) versus Its RivalsSeptember 11, 2023 | americanbankingnews.comVivani Medical (VANI) versus Its Peers Head-To-Head ComparisonSeptember 10, 2023 | finance.yahoo.comInsider Buys Additional US$50k In Vivani Medical StockSeptember 21, 2023 | The Oxford Club (Ad)Better Than Oil Stocks?The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. September 8, 2023 | benzinga.com50K Reasons To Be Bullish On Vivani Medical StockSeptember 8, 2023 | msn.comVivani Medical Director William Gregg buys $50.2k worth of shares - filingSeptember 7, 2023 | finance.yahoo.comVivani Medical to Present at the Boulder Peptide SymposiumSeptember 5, 2023 | finance.yahoo.comVivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10August 16, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)August 14, 2023 | seekingalpha.comVivani Medical GAAP EPS of -$0.13 misses by $0.02August 14, 2023 | chron.comVivani Medical: Q2 Earnings SnapshotAugust 14, 2023 | finance.yahoo.comVivani Medical Reports Second Quarter Financial Results and Provides Business UpdateJuly 11, 2023 | finance.yahoo.comVivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis SystemJune 23, 2023 | benzinga.comDirector at Vivani Medical Acquires Company Stock Options Worth 32,121 SharesJune 21, 2023 | benzinga.comBoard Member at Vivani Medical Acquires Company Stock Options Worth 32,121 SharesJune 21, 2023 | benzinga.comVivani Medical Director Awarded $39K Worth of Stock OptionsJune 14, 2023 | finance.yahoo.comVivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-VestJune 13, 2023 | finance.yahoo.comIs Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?June 8, 2023 | seekingalpha.comIPO Update: Cortigent Readies $15 Million Mini-IPOJune 8, 2023 | msn.comCortigent, vision restoration device maker, sets terms for $15M IPOJune 6, 2023 | uk.finance.yahoo.comVANI - Vivani Medical, Inc.May 15, 2023 | sfgate.comVivani Medical: Q1 Earnings SnapshotSee More Headlines Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address VANI Company Calendar Last Earnings8/14/2023Today9/21/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VANI CUSIPN/A CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees50Year FoundedN/APrice Target and Rating Average Stock Price Forecast$7.00 High Stock Price Forecast$7.00 Low Stock Price Forecast$7.00 Forecasted Upside/Downside+644.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,890,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-44.95% Return on Assets-35.23% Debt Debt-to-Equity RatioN/A Current Ratio5.11 Quick Ratio5.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.87 per share Price / Book1.08Miscellaneous Outstanding Shares50,819,000Free Float22,553,000Market Cap$47.75 million OptionableOptionable Beta2.64 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Adam Mendelsohn Ph.D. (Age 41)CEO & Director Comp: $312.01kMs. Brigid Ann Makes (Age 67)Chief Financial Officer Comp: $204.63kMr. Truc Le M.B.A. (Age 70)Chief Operations Officer Comp: $337.2kDr. Lisa E. Porter M.D. (Age 59)Chief Medical Officer Mr. Donald Dwyer M.B.A.Chief Bus. OfficerKey CompetitorsSoleno TherapeuticsNASDAQ:SLNOMovanoNASDAQ:MOVENocturne AcquisitionNASDAQ:MBTCBioSig TechnologiesNASDAQ:BSGMelectroCoreNASDAQ:ECORView All CompetitorsInsiders & InstitutionsGregg WilliamsBought 66,743 shares on 9/18/2023Total: $64,073.28 ($0.96/share)Gregg WilliamsBought 35,036 shares on 9/14/2023Total: $33,284.20 ($0.95/share)Gregg WilliamsBought 1,854 shares on 9/11/2023Total: $1,761.30 ($0.95/share)Gregg WilliamsBought 33,700 shares on 9/7/2023Total: $31,678.00 ($0.94/share)Gregg WilliamsBought 4,997 shares on 9/5/2023Total: $4,647.21 ($0.93/share)View All Insider TransactionsView All Institutional Transactions VANI Stock - Frequently Asked Questions Should I buy or sell Vivani Medical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vivani Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" VANI shares. View VANI analyst ratings or view top-rated stocks. What is Vivani Medical's stock price forecast for 2023? 1 equities research analysts have issued 1 year target prices for Vivani Medical's stock. Their VANI share price forecasts range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 644.9% from the stock's current price. View analysts price targets for VANI or view top-rated stocks among Wall Street analysts. How have VANI shares performed in 2023? Vivani Medical's stock was trading at $0.8497 at the start of the year. Since then, VANI stock has increased by 10.6% and is now trading at $0.9397. View the best growth stocks for 2023 here. When is Vivani Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our VANI earnings forecast. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) announced its earnings results on Monday, August, 14th. The company reported ($0.13) earnings per share for the quarter. What is Vivani Medical's stock symbol? Vivani Medical trades on the NASDAQ under the ticker symbol "VANI." Who are Vivani Medical's major shareholders? Vivani Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Tanager Wealth Management LLP (3.25%), BlackRock Inc. (0.42%), Geode Capital Management LLC (0.28%), Charles Schwab Investment Management Inc. (0.06%), Cutler Group LLC CA (0.00%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Vivani Medical's stock price today? One share of VANI stock can currently be purchased for approximately $0.94. How much money does Vivani Medical make? Vivani Medical (NASDAQ:VANI) has a market capitalization of $47.75 million. The company earns $-13,890,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. How can I contact Vivani Medical? Vivani Medical's mailing address is 13170 TELFAIR AVE., SYLMAR CA, 91342. The official website for the company is www.vivani.com. The company can be reached via phone at (818) 833-5000, via email at investors@secondsight.com, or via fax at 818-833-5067. This page (NASDAQ:VANI) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.